Research: Efficacy of Solifenacin for Overactive Bladder Symptoms, Symptom Bother, and Health-Related Quality of Life in Patients by Duration of Self-Reported Symptoms: A Secondary Analysis of the VIBRANT Study


Identification: unj_jf12_04
Issue: January-February 2012
Volume: Volume 32 Number 1


Description

Acknowledgments and Author Contributions: The VIBRANT Study was undertaken with a research grant from Astellas Pharma U.S.; Inc. and GlaxoSmithKline. Editorial support; including writing assistance; was provided by Linda A. Goldstein; PhD; a medical writer at Envision Pharma; Inc.; and was funded by Astellas Pharma Global Development; Inc. and GlaxoSmithKline.

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

References